Novo Nordisk (NVO) stock took a hit this week, after a Super Bowl ad highlighted a growing challenge to the company’s ...
Lawmakers are calling out advertisement of prescription of injectable weight-loss drugs without disclosing safety and risk information.
The past few days haven't been kind to most stocks in the white-hot obesity drugs space. One developer of a weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback